Genes undergoing substantial evolutionary shifts in their expression profiles are often modulated by critical epigenomic changes that are among the primary targets of selection in evolution. Here, we investigate the evolution of epigenetic regulatory activities and their interplay with gene expression in human and non-human primate lineages. We extensively profiled a new panel of human and non-human primate lymphoblastoid cell lines using a variety of NGS techniques and integrated genome-wide chromatin contact maps to define gene regulatory architectures. We observe that epigenetic and sequence conservation are coupled in regulatory elements and reflect the impact of their activity on gene expression. The addition or removal of strong and poised promoters and intragenic enhancers is frequent in gene expression changes during recent primate evolution. In contrast, novel human-specific weak intragenic enhancers, dormant in our cell lines, have emerged in genes showing signals of recent adaptive selection, suggesting that they echo important regulatory innovations in other cell types. Among the genes targeted by these regulatory innovations, we find key candidate drivers of recently evolved human traits, such as FOXP2 or ROBO1 for speech and language acquisition, and PALMD for neocortex expansion, thus highlighting the importance of regulatory changes in human evolution.
Introduction
Changes in chromatin structure and gene regulation are thought to play a crucial role in evolution 1, 2 . Gene expression differences have been extensively studied in a variety of species and conditions [3] [4] [5] [6] . However, little is known about how fine-tuning regulatory changes evolved in closely related species, even from a human perspective. Previous work has focused on the dynamics of the establishment and removal of strongly active regulatory elements during the evolution of mammals -mainly defined from ChIP-seq experiments on few histone marks [7] [8] [9] [10] .
These analyses suggested that enhancers have evolved faster than promoters 8, 11 . It has also been highlighted that the number of strongly active enhancers located near a gene is important for the conservation of gene expression 9 . Moreover, in a selected group of primates -mostly chimpanzees and macaques-changes in histone mark enrichments are associated with gene expression differences 12 . Several studies have also targeted the appearance of humanspecific methylation patterns 13, 14 and strongly active promoters and enhancers in different anatomical structures and cell types 8, 10 . All these studies have shown that comparative epigenomics is a powerful tool to investigate the evolution of regulatory elements 15, 16 . Yet, the integration of multi-layered coherent epigenome data is essential for investigating recent evolutionary time frames, for example within human relatives.
Here, we provide an in-depth view of the recent evolution of gene regulatory architectures using a homologous cellular model system in human and non-human primates. For this, we . Chromatin states were hierarchically grouped according to their epigenomic state (promoter, enhancer or non-regulatory) and activity (strong, weak or poised).
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In contrast to other commonly used definitions of promoter and enhancers limited to strongly active regions 7, 8 , the multi-layered integration of this epigenetic resource allows the additional definition of weak and poised activities. These activities are of particular relevance to improve the definition of regulatory regions and explore the regulatory potential of regions whose activity can differ in other cell types or conditions. Hence, regulatory elements in each sample were identified as genomic regions displaying such regulatory states (Supplementary Materials). Altogether, this catalog of regulatory elements provides a comprehensive view of the regulatory landscape both in humans and in our closest relatives.
Results

Evolution of promoter and enhancer epigenetic states in human and non-human primates
We identified 29,693 clusters of one-to-one orthologous regions present in all species ( Figure   S47 ) where a promoter or enhancer state was detected in at least one species -hereinafter referred to as 'regulatory regions' (Supplementary Materials, Supplementary Table 4 ). The presence of regulatory states in these regions is highly conserved, with 61% of them having a detectable regulatory state in all five species (Fig. 1a) . Consistent with previous studies in more distant species 9 , we observed that the presence of promoter states in regulatory regions is more conserved than that of enhancer states (68% and 56% of promoters and enhancers are fully conserved, respectively, Chi-square test, P < 2.2 x 10 -16 ). However, the high conservation values of enhancer states indicates that a great amount of them have conserved their regulatory potential -regardless of their activity-during a recent evolutionary time frame.
Next, we investigated changes in the regulatory state during the evolution of human and nonhuman primates (Fig. 1a ). About 97% of the regions undergoing either gains or losses of regulatory states correspond to enhancers recently established or removed in primates (Supplementary Table 5 -7) . Most gains/losses are species-specific (63% in enhancers and 91% in promoters). We observed a preferential loss of conserved enhancers over promoters 6 (22% and 3% of the regions with the corresponding state conserved in the remaining species respectively, Chi-square test, P < 2.2 x 10 -16 ). The human lineage shows higher rates of both gains and losses of enhancer states than the chimpanzee lineage (Chi-square test, P < 10 -12 in both cases), while it has accumulated fewer gains and losses in promoter states than the latter (Chi-square test, P = 1.5 x 10 -3 and 4.3 x 10 -12 , respectively, Supplementary Fig. 48 ).
In addition, we found 721 regulatory regions showing signals of robust repurposing (Supplementary Table 8 ). Most of these cases (72%) reflect recent species-specific events in regions with conserved states. 347 promoter states are repurposed from conserved enhancer states and 175 enhancer states from conserved promoter states, with a significant enrichment in promoter to enhancer repurposing (Chi-square test, P < 2.2 x 10 -16 ). However, the lower number of promoters in the genome limits the number of cases of promoter-to-enhancer repurposing, leading to most (92%) species-specific enhancer states being gained from regions with non-regulatory states in all the other species. In contrast, the higher number of enhancers allows most (53%) species-specific promoters to arise from conserved enhancer repurposing (in agreement with previous observations in vertebrates 18 . Taken together, 99% of the changing regulatory regions and 88% of the fully conserved regions display enhancer configurations, highlighting their fundamental role in the recent evolution of regulatory landscapes in human and non-human primates.
Enhancer and promoter regulatory activities show specific evolutionary dynamics
While the study of the evolution of enhancer and promoter states provides a global perspective, a detailed understanding of the underlying evolutionary dynamics requires the consideration of their activities. The different enhancer and promoter activities show characteristic conservation patterns (Supplementary Materials and Supplementary Fig. 1b ).
Strong promoter activities are highly conserved, whereas poised and weak promoter activities show poor conservation in human and non-human primates. As most of the detected promoter states (85.9%) are strongly active ( Fig. 1c ), there is a relatively small number of regions (686 regions) changing from/to/between promoter activities. Strong enhancer activities are also more conserved than poised and weak activities, but the three of them show similar conservation patterns ( Fig. 1d ). All enhancer activities in primates display a U-shaped conservation pattern, reflecting their intermediate levels of epigenetic conservation. This highlights the importance of enhancer activities in defining both common and divergent cellular configurations in every lineage .
We observed that most gains/losses of enhancer states involve strong and weak activities ( Supplementary Fig. 48 ). Strong enhancer activities are rarely gained whereas weak enhancer activities are both gained and lost at higher rates. The smaller number of gains and losses of strong enhancers in the human lineage contrasts with a previous study targeting gains of strong enhancers in brain 8 , probably reflecting tissue-specific differences. Promoter activities are gained and lost at very different rates. Losses correspond exclusively to strong promoter activities, while weak activities are preferentially gained. Consequently, the comparatively higher rates in chimpanzee-specific changes imply a substitution of strong with weak promoter activities in different regions. These gains and losses in promoters, though potentially relevant for gene expression, are infrequent in primate evolution (4.4% of the regions with annotated promoter states in primates but only 4 human-specific cases and none associated with protein coding genes, Supplementary Tables 5-6 ). Taken together, the observed numbers of conserved and changing enhancers support the prevalent role of enhancer activities both in regulatory conservation and innovation in recent human evolution.
We next evaluated the sequence conservation of the different activities. The sequences of strong promoter activities are highly conserved, and the more conserved the state, the higher the sequence conservation ( Fig. 1c and Supplementary Materials). This indicates that their incorporation or removal implies radical changes in the evolutionary constraint of the region.
On the other hand, sequence and epigenomic conservation of poised promoters are not linked, but their high sequence conservation suggests a possible strong activity in other cell types or 8 conditions. Finally, sequences of weak promoters are poorly conserved suggesting a less relevant regulatory role. Like promoters, strong and poised enhancers show high levels of sequence conservation in human and non-human primates, while weak enhancers are much less conserved ( Fig. 1d ). However, enhancers show a direct association of activity conservation and sequence conservation for all the activity types, which is consistent with corresponding differences in evolutionary constraint. This observation also indicates that the activity conservation of enhancers and strong promoters in our cellular model is a good proxy of their functional importance during human and non-human primate evolution.
Definition of gene regulatory architectures
We have shown that the regulatory state and activity of a region strongly conditions its genomic and epigenomic conservation in human and non-human primates. However, these activities are defined without considering their interaction with their target genes. We defined gene regulatory architectures by linking the regulatory elements with their putative target genes. We retrieved over 350,000 (69.2% of the regulatory elements) gene-element assignments for all five species based on a combination of genome proximity and available 3D contact maps for human LCLs [19] [20] [21] (chromatin contacts were projected to non-human primates based on the orthology of the interacting regions, Supplementary Materials, Fig. 2a , Supplementary Figs. Tables 9-15 ). The remaining unassigned orphan regions are depleted in strong and poised activities (Chi-square test, P < 2.2 x 10 -16 ) and show a poor sequence conservation (Mann-Whitney U test, P < 2.2 x 10 -16 ; Fig. 2b ). The higher evolutionary constraint in the regulatory regions linked to genes is reflected also in the higher epigenomic conservation of the weak enhancer activities ( Fig. 2c ), suggesting that we were able to assign target genes for the most relevant regulatory regions in our system.
54-58 and Supplementary
Given that gene expression is controlled by a combination of short-and long-distance regulatory interactions 22 , elements in our gene regulatory architectures were classified in five regulatory components according to the nature of their association with their target genes (3D 9 contact and/or genomic position relative to the gene). We defined promoters, intragenic enhancers, promoter-interacting enhancers, proximal enhancers and enhancers-interacting enhancers for every gene, regardless of their actual epigenomic state. It is important to note that the same gene-architectural component can display enhancer or promoter epigenetic states in different conditions. For this reason, we decided to define our components independently of their regulatory states. However, regulatory activities are in strong agreement with our regulatory components ( Fig. 2d and Supplementary Fig. 55 ), with regulatory activities being globally enriched in their analogous regulatory components (Chi-square test, P < 2.2 x 10 -16 ).
Role of the gene-architectural components in gene expression and its evolution in human and non-human primates
Our observations suggest that the evolutionary conservation of an element reflects its importance in the regulation of its target gene. However, the actual importance of each type of component and regulatory state in gene regulation and in its evolutionary changes remains to be elucidated. Previous analyses have shown that gene expression can be predicted based on the pseudo-quantitative ChIP-seq signals from informative marks in regulatory regions, mostly promoters and gene surroundings 12, 23, 24 . We reasoned that the relevance of the different gene-architectural components in gene regulation could be deduced from the strength of these co-dependencies. In this way, types of regulatory components important for regulating gene expression are expected to show histone enrichments coordinated with gene expression levels along all the genes in human and non-human species. Covariations in tightly interdependent multivariate systems are the result of the complex network of dependencies and often offer a distorted view of their actual underlying causal relationships [25] [26] [27] . To unravel this scenario, we used partial correlation analyses to define the common network of direct codependencies between RNA-seq and ChIP-seq signals for protein-coding genes. We also used generalized linear models to determine the ability of key components of our regulatory architectures to explain gene expression (Supplementary Materials).
Protein-coding genes show a high variety of regulatory architectures ( Figure S54 ) and previous studies have shown that conservation in the number of strong enhancers is important for the evolution of gene expression in more distant species 9 . Thus, for simplicity, we considered an additive scenario in which ChIP-seq signals of all elements in each genearchitectural component were aggregated for promoter and enhancer states separately. This approach accommodates all the different combinations of components and elements found in our regulatory architectures in 50 regulatory variables (2 states x 5 components x 5 histone marks). We performed a partial correlation analysis of gene expression and these regulatory variables (Supplementary Materials) to elucidate the relevance of the different types of regulatory components and states for explaining gene expression levels in human and nonhuman primate species. The network of partial correlations shows that the RNA-seq signal is specifically explained by the combination of promoters and intragenic enhancers ( Fig. 3a and Supplementary Fig. 59 ). Interestingly, we also observed co-dependencies between the elements of these two components indicating that their interdependence can contribute to gene regulation. Promoters and intragenic enhancers also show negative Pearson's correlations between their histone mark signals ( Supplementary Fig. 60 ), suggesting that promoters and intragenic enhancers could be part of different complementary regulatory mechanisms.
To evaluate the strength of the co-dependence of the transcriptional output with promoters and intragenic enhancers, we predicted protein-coding gene expression levels from ChIP-seq signals in these core regulatory regions. For this, we fitted generalized linear models based only on the normalized enrichments of H3K27ac, H3K27me3 and H3K36me3 in promoters and intragenic enhancers, considering first-order interactions between them (Supplementary Materials). This multivariate model explains 72% of gene expression variability ( Supplementary Fig. 61, Supplementary Materials) , outperforming a model including all histone marks (and ATAC-seq) in all the elements without first-order interactions (65%, Supplementary Fig. 62 ). These results confirm the high influence of both genic promoters and intragenic enhancers on gene regulation and support the previously unknown interdependence between them.
We then investigated the contribution of the different components to gene expression changesn. The specific contribution of strong enhancers to gene expression evolution can be explained by the number of enhancers in the genomic neighborhood of the gene 9 . We dissected the different effect of regulatory states and activities for each gene-architectural component in gene expression changes, in terms of their changes in number in the regulatory architectures of orthologous genes (Fig. 3b, Supplementary Materials) . Consistent with all components being (directly or indirectly) connected to gene expression in our partial correlation network (Fig. 3a) , differences in the number of every regulatory component are significantly associated with inter-species gene expression differences. However, the contribution to this effect of each component depends on its regulatory state and activity. The presence of promoter components (for strong promoter and poised enhancer activities) and the number of intragenic enhancers (for strong enhancer and poised enhancer activities) show the most robust associations with gene expression differences. Proximal enhancers (for strong, weak and poised activities) also show significant, although less supported associations that according to our partial correlation analysis could occur through promoter activities in promoter components (Fig. 3a ). Enhancers interacting with promoters (for strong promoter and enhancer activities) and with other enhancers associated with the gene (for weak enhancers and the combination of both poised activities) also show significant but modest effects (Fig. 3b ).
Weak enhancers echo the regulatory activity of different cell types
Next we assessed the functional profiles of the genes targeted by conserved and humanspecific promoter and intragenic enhancer components ( Supplementary Tables 16-19 ). The small number of genes carrying human-specific strong promoters and enhancers show no significant enrichments. Fully conserved strong promoter activities in promoter components and strong enhancers in intragenic enhancers show overlapping enrichments for housekeeping intracellular functions, associated with metabolism, chromatin organization or regulation of the cell cycle (Fisher's exact test, BH correction FDR<0.05, Supplementary   Tables 20-23 ). These enrichments are coherent with their essential roles and reflect the proliferative state of these cell lines.
We explored the role of weak enhancers in our architectures, since their functional interpretation is not obvious. Weak enhancers are more conserved when they are associated with the regulatory architectures ( Fig. 2c ). However, they seem not to be very relevant for gene expression changes in our primate cell lines (Fig. 3b ). Weak enhancers are characterized by the presence of H3K4me1 in the absence of H3K27ac and H3K27me3 (Supplementary Figs. 16-17, Supplementary Materials). Intronic H3K4me1 sites are specifically enriched in brain 28 and alterations in the regulation of H3K4 methylation have been associated with a variety of neurodevelopmental disorders 29 . Therefore, intragenic enhancers may have a particularly relevant role in the epigenetic regulation of the central nervous system. The exact function of H3K4me1 in enhancers remains unclear 30 but in the absence of H3K27ac they have been proposed to mark 'primed' enhancers 31, 32 or even to be involved in expression fine-tuning 30 .
We hypothesized that weak intragenic enhancers could reflect the degree of regulatory conservation in genes active in other cell types or conditions. For this reason, we analyzed conserved and human-specific weak intragenic enhancers as a proxy of regulatory elements potentially relevant to the evolution of other cell types. We observed that genes with conserved weak intragenic enhancers are highly enriched in functions related to ion transmembrane transport, neuronal genes and blood vessel development (Fisher's exact test, BH correction, FDR < 0.05; Supplementary Tables 24-25 , Supplementary Materials) . In fact, we found that they were enriched in genes with cerebral cortex-and kidney-specific gene expression (hypergeometric test, BH correction, 62 genes and P = 1.3 x 10 -4 ; 18 genes and P = 1.3 x 10 -13 5 , respectively; Fig. 4a and Supplementary Fig. 63) . Similarly, genes with human-specific weak intragenic enhancers are enriched in neuronal and membrane genes (Fisher's exact test, BH correction, FDR < 0.05; Supplementary Table 26 -28, Supplementary Materials), reinforcing the involvement of weak intragenic enhancers in the regulation of genes associated with transmembrane transport, especially in synapsis. This is consistent with their enrichment in genes with cerebral cortex-specific gene expression (hypergeometric test, BH correction, 26 genes and P = 3.5 x 10 -6 ; Fig. 4b ).
Novel weak intragenic enhancers mark regulatory innovations in candidate driver genes of human adaptation
Although the direct role of human-specific weak intragenic enhancers in the regulation of neuronal processes remains to be elucidated, they point towards the acquisition of regulatory innovations in a small set of genes. Among the 77 genes with human-specific weak intragenic enhancers, we found some particularly interesting cases (detailed list in Supplementary Table   28 ). For these instances we explored their epigenetic context in other cell types and tissues 33 finding strong or weak enhancer activities in most of the cases with cell types matching their functions ( Fig. 4 and Supplementary Figs. 64-75) .
The presence of human-specific weak intragenic enhancers in these examples is associated with two main regulatory scenarios (Fig. 4c,d and Supplementary Figs. 64-75 ), according to an independent analysis in human cell lines 33 . First, we found cases as FOXP2 ( Fig. 4c and Supplementary Fig. 64) , where our human-specific intragenic enhancers typically show heterochromatin or elongation states in most cell types, but display weak enhancers (or it is surrounded by such) in more specific tissues (often brain, lung and/or aorta). Second, we detected cases as PALMD ( Fig. 4d and Supplementary Fig. 65) showing weak or strong enhancer states in more tissues. These two scenarios might imply the presence of two levels of specificity. One of them associated with activation in very specific tissue regions, moments or conditions and a second scenario reflecting a more global activation in the targeted tissues.
Two of the genes with human-specific acquisition of weak intragenic enhancers are FOXP2
and ROBO1 ( Fig. 4a and Supplementary Figs. 66-68) , both of which are involved in human speech and language acquisition 34, 35 and may have been important during the evolution of the human lineage since the split from chimpanzees 34, 35 . The SORCS3, ADGRL2 and PTPRG genes ( Supplementary Figs. 69-71) , like FOXP2, are associated with human-accelerated conserved non-coding sequences and show differential expression in brain areas involved in speech and language processing 36 . SYBU also shows signals of adaptive selection in the human lineage 37 and has been associated with cognitive decline in neurodegenerative diseases 38 . PRSS12 ( Supplementary Fig. 72 ) shows a putative signal of positive selection in humans 39 and modulates hippocampal function and social interaction in mice 40 . PALMD ( Fig. 4b and Supplementary Fig. 65 ) has been recently proposed as a driver of the evolutionary expansion of the neocortex in mammals 41 and, in addition to present a humanspecific weak intragenic enhancer, it contains a large number of non-synonymous changes fixed in modern humans after the split from Neanderthals 42 . This suggests that PALMD might also have a role in the expansion of the neocortex in humans, maybe in coordination with other genes, such as ARHGAP11B 43 . ADAM18 ( Supplementary Fig. 73 ) is involved in spermatogenesis and also carries non-synonymous changes fixed in modern humans 42 .
Selection on ADAM18 has also been associated with the evolution of promiscuity in primates 44 .
Besides these genes, we found many other interesting cases both related and unrelated to neuronal functions. For instance, the TBX15 gene ( Supplementary Fig. 74 ), which is associated with adipose tissue differentiation and body-fat distribution, contains a Denisovanlike haplotype subject to adaptive introgression in modern humans from Greenland 45 . CFTR ( Supplementary Fig. 75 ) is another interesting case carrying a human-specific weak intragenic enhancer. Mutations in CFTR are responsible for cystic fibrosis 46 and the high allele frequency of its pathological allele in European populations suggests the existence of a heterozygous adaptive advantage 47 . However, given that one of the human cell lines used in this study is of Yoruban origin (GM19150 cell line, see Supplementary Fig. 2) and also shows the weak enhancer linked to CFTR, the acquisition of this regulatory element probably precedes the introduction of this allele. Taken together, our results show that human-specific acquisition of weak intragenic enhancers in LCLs points to genes that were potentially subject to adaptation in the human lineage at different timescales with tissue-specific activation and expression patterns.
Discussion
The evolution of human and non-human primates is an area of major interest, in which the access to direct biological material is often limited by ethical, legal and practical constraints.
In this study we have generated a unique, comprehensive and unified dataset of epigenomic landscapes in LCLs for human and four non-human primates. Despite the artificial nature of our cell model [48] [49] [50] , previous studies have shown the value of LCLs as an experimentally convenient model of somatic cells that accurately resembles the phenotype of its cell type of origin 51 and which can be robustly used for comparative studies in humans and primates 12, [52] [53] [54] . Moreover, its clonality ensures a cell type-specific experimental system reducing the confounding factors associated with cell population diversity in bulk tissue samples. With this cell model, we could reproduce biological observations about the dynamics of the evolution of regulatory elements previously obtained in more distant species using liver samples 7, 9, 18 .
Moreover, we have expanded these observations to explain how these dynamics are a consequence of the different evolutionary constraints associated with their regulatory activities. Therefore, we prove that considering weak and poised activities is of major relevance to better understand the evolution of regulatory regions.
In LCLs, the human lineage shows higher rates of incorporation and removal of strong enhancers, but lower rates for strong promoters than the chimpanzee lineage. These rates are likely to differ between different cell types, as they convey information about the phenotypic changes and the functional profiles associated with each cell type. In fact, a recent work focused on strong activities in bulk brain samples showed a higher number of changes in human promoters compared to chimpanzee 8 . These observations suggest that there is room for defining cell type-specific epigenomic evolutionary signatures based on the changes in strong regulatory activities. We and others have shown that cell lines provide an experimentally sound and biologically informative resource for this research, even more in the context of endangered species. Future studies performing cell-type-aware comparative epigenomics will provide additional insights into the dynamics of the evolution of the regulatory landscapes and their integration will help broaden the understanding of the evolution of more complex phenotypic traits.
Our results show that the association of regulatory components with gene expression reflects the logic of the structural configuration of the regulatory architecture and influences the evolution of the regulatory landscape in human and non-human primates. In brief, promoter and intragenic enhancer components constitute the interdependent core of these architectures explaining gene expression levels. Proximal and promoter-interacting enhancers are codependent with promoter components, and enhancer-interacting enhancers are associated with promoter interacting enhancers. We observed that the evolutionary behavior of the regulatory components is highly conditioned by its association with gene expression.
Acquisition or removal of these strong promoter activities in promoter components or strong and poised enhancer activities in intragenic enhancers consistently co-occurs with gene expression changes between primate species and affects the evolutionary constraint of the component. Despite the weaker and indirect co-dependencies of the remaining components, they can still be instrumental for gene expression evolution through their influence on promoters and intragenic enhancers. Our analyses demonstrate that for understanding the evolution of regulatory landscapes, it is fundamental to unravel their actual role in gene regulation. This conceptual framework provides a starting point for future in-depth investigations on the interdependence of different regulatory regions and mechanisms in the evolution of gene regulation. In this sense, we stress the importance of embracing higher levels of complexity in order to achieve a more detailed description of the regulatory processes.
Interestingly, major insights about this process can arise from the analysis of the regulatory elements with a negligible regulatory role in our system. Weak intragenic enhancers seem to carry information about the degree of regulatory innovation in a broader context than the studied cell type (mostly in transmembrane transporters and neuronal functions). Interestingly, gains of these elements in the human lineage are associated with candidate genes that may have driven human adaptation in several important traits at different timescales. This observation suggests that changes in the regulatory potential of intragenic enhancers lead to conformational epigenetic changes that can be observed in cell types where they are not active. These echoing regulatory states provide an unexpected window to the evolution of regulatory landscapes in the human lineage. Further research will be needed to clarify the actual role of these elements in the differential regulation of these genes. We conclude that differences in the regulatory roles and activities deeply condition the evolutionary dynamics of epigenomic landscapes and their association with gene expression changes. Our insights call for the incorporation of better integrative datasets and key molecular regulatory details in comparative evolutionary studies to better understand the interplay between epigenetic regulation and gene expression in recent human evolution.
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